Home » Posts tagged 'primary prevention'
Tag Archives: primary prevention
2018, N3 fatty acid supplements for prevention of CVD and cancer, NEJM
2018, Vitamin D3 for prevention of CVD and cancer, NEJM
2018, Aspirin for primary prevention in patients with Diabetes mellitus, NEJM
2018, Effect of Aspirin in elderly at moderate CVD risk | LANCET
2018, Effect of Aspirin on CV Events and Bleeding in the Healthy Elderly | NEJM
USPSTF/ACC/AHA guidelines for Statin Use for the Primary Prevention of Cardiovascular Disease in Adults
The USPSTF and ACC/AHA guidelines for statin use in adults aged 40-75 years are consistent over level of recommendation. Adults who have no history of cardiovascular disease but have 1 or more risk factors for developing CVD along with >10% ASCVD risk are recommended to be started on low- to moderate dose statin. (USPSTF = B). The ACC/AHA however recommends moderate to high dose statin for ASCVD risk of >7.5% for primary prevention (ACC/AHA Level I). The above visual abstract summarizes both the societies’ recommendations in to one easy to use graphic.